EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation

Xu Zhang iD, Chi Chen, Yan Wang, Jun Xu

Journal of Gastroenterology and Hepatology · 2024-11 · 39 (11) · 2272-2280

DOI: 10.1111/jgh.16693 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 07.08.2024. Verfasst von Xu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Academy of Medical Sciences, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Shanxi Provincial Key Laboratory of Digestive Diseases and Organ Transplantation, Scientific and Technological Innovation Base for Evaluation of Immune Rejection after Liver Transplantation, Natural Science Foundation of Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver transplantation (LT) is an effective method for curing hepatocellular carcinoma (HCC). However postoperative tumor recurrence can lead to higher mortality rates. To select suitable candidates for LT, the Milan Criteria (MC) were first proposed based on tumor morphological characteristics. For those patients who meet the MC, the MC can effectively reduce the postoperative tumor recurrence rate and improve the prognosis of patients undergoing LT. It has always been internationally recognized as the gold standard for selecting candidates for LT, marking a milestone in the history of LT for HCC. However, its strict conditions exclude some HCC patients who could benefit from LT. Therefore, comprehension consideration criteria, including serum biomarkers, tumor histology, and other factor, have been continuously proposed in addition to tumor morphology. This article summaries the prediction model for HCC recurrence after LT from five aspects: tumor morphology, serum markers, histopathology, cellular inflammatory factors and downstaging treatment before transplantation. The aim is to assist clinicians in accurately assessing HCC status, selecting appropriate liver transplant candidates, maximize graft and patients' survival, and optimizing the utilization of social health resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLiver TransplantationNeoplasm Recurrence, LocalBiomarkers, TumorHumansRisk AssessmentPatient SelectionRiskNeoplasm StagingPrognosis

Stichwörter der Autor:innen

Hepatocellular carcinomaLiver transplantationPrognosisRecurrenceSurvival

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Academy of Medical Sciences, Shanxi Medical University, Taiyuan, China.
  • Department of Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Hepatobiliary and Pancreatic Surgery and Liver Transplantation Center, First Hospital of Shanxi Medical University, Taiyuan, China.

ORCID-Profile: Xu Zhang

Förderung

  • Shanxi Provincial Key Laboratory of Digestive Diseases and Organ Transplantation
  • Scientific and Technological Innovation Base for Evaluation of Immune Rejection after Liver Transplantation
  • Natural Science Foundation of Shanxi Province

Zitieren

APA

Zhang, X., Chen, C., Wang, Y., & Xu, J. (2024). Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation. Journal of Gastroenterology and Hepatology, 39(11), 2272-2280. https://doi.org/10.1111/jgh.16693

Vancouver

Zhang X, Chen C, Wang Y, Xu J. Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation. Journal of Gastroenterology and Hepatology. 2024;39(11):2272-2280. doi:10.1111/jgh.16693

BibTeX
@article{Zhang2024,
  author = {Zhang, Xu and Chen, Chi and Wang, Yan and Xu, Jun},
  title = {Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  volume = {39},
  number = {11},
  pages = {2272--2280},
  doi = {10.1111/jgh.16693}
}
Kostenlos starten →